Français
ItalianoBond Bausch Health Companies 11% ( US071734AQ04 ) in USD
| Issuer | Bausch Health Companies | ||||||
| Market price |  104.38 % ⇌ |
||||||
| Country |  Canada
|
||||||
| ISIN code |
 US071734AQ04 ( in USD )
|
||||||
| Interest rate | 11% per year ( payment 2 times a year) | ||||||
| Maturity | 30/09/2028 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 1 000 USD | ||||||
| Total amount | 1 774 067 000 USD | ||||||
| Cusip | 071734AQ0 | ||||||
| Standard & Poor's ( S&P ) rating | B- ( Highly speculative ) | ||||||
| Moody's rating | Caa1 ( Substantial risks ) | ||||||
| Next Coupon | 30/09/2026 ( In 35 days ) | ||||||
| Detailed description |
Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products. The Bond issued by Bausch Health Companies ( Canada ) , in USD, with the ISIN code US071734AQ04, pays a coupon of 11% per year. The coupons are paid 2 times per year and the Bond maturity is 30/09/2028 The Bond issued by Bausch Health Companies ( Canada ) , in USD, with the ISIN code US071734AQ04, was rated Caa1 ( Substantial risks ) by Moody's credit rating agency. The Bond issued by Bausch Health Companies ( Canada ) , in USD, with the ISIN code US071734AQ04, was rated B- ( Highly speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||